Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: Lack of prediction of tumor significance for men with nonpalpable prostate cancer

Journal of Urology

Volumn 166, Issue 1, 2001, Pages 104-110

  Noguchi, Masanori ^a   Stamey, Thomas A ^a   McNeal, John E ^a   Yemoto, Cheryl M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biopsy needle; Prostate specific antigen; Prostatectomy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER SCREENING; CANCER SIZE; CONTROLLED STUDY; CORRELATION FUNCTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BLOOD LEVEL; TREATMENT PLANNING;

EID: 0034972409     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(05)66086-7     Document Type: Article

References (17)

1. PSA-detected (clinical stage T1c or B0) prostate cancer: Pathologically significant tumors
2. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer
3. Localized prostate cancer: Relationship of tumor volume to clinical significance for treatment of prostate cancer
4. Detection of clinically significant prostate cancer by transrectal ultrasound-guided systemic biopsies
5. Making the most out of six systematic sextant biopsies
6. Assessment of morphometric measurements of prostate cancer volume
7. Biological determinants of cancer progression in men with prostate cancer
8. Gleason grading of prostatic needle biopsies: Correlation with grade in 316 matched prostatectomies
9. Effect of the number of core biopsies of the prostate on predicting Gleason score of prostate cancer
10. Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: Accuracy and clinical implications
11. Discrepancy between Gleason scores of biopsy and radical prostatectomy specimens
12. Core cancer length in ultrasound-guided systematic sextant biopsies: A preoperative evaluation of prostate cancer volume
13. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis
14. Relationship between serum prostate specific antigen, needle biopsy findings, and histopathologic features of prostatic carcinoma in radical prostatectomy tissues
15. One core positive prostate biopsy is a poor predictor of cancer volume in the radical prostatectomy specimen
16. Nonpalpable stage T1c prostate cancer: Prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings
17. Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy